ArticleInflammopharmacology2022
Nuciferine attenuates lipopolysaccharide-stimulated inflammatory responses by inhibiting p38 MAPK/ATF2 signaling pathways.
Sung-Min Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it